FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010996890> ?p ?o ?g. }

• W3010996890 endingPage "2030" @default.
• W3010996890 startingPage "2017" @default.
• W3010996890 abstract "Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib in transgenic mouse models of EGFRL858R -induced lung adenocarcinoma and found that it is mediated largely through secondary mutations in EGFR-either C797S or L718V/Q. Analysis of circulating free DNA data from patients revealed that L718Q/V mutations almost always occur in the context of an L858R driver mutation. Therapeutic testing in mice revealed that both erlotinib and afatinib caused regression of osimertinib-resistant C797S-containing tumors, whereas only afatinib was effective on L718Q mutant tumors. Combination first-line osimertinib plus erlotinib treatment prevented the emergence of secondary mutations in EGFR. These findings highlight how knowledge of the specific characteristics of resistance mutations is important for determining potential subsequent treatment approaches and suggest strategies to overcome or prevent osimertinib resistance in vivo. SIGNIFICANCE: This study provides insight into the biological and molecular properties of osimertinib resistance EGFR mutations and evaluates therapeutic strategies to overcome resistance. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/10/2017/F1.large.jpg." @default.
• W3010996890 created "2020-03-23" @default.
• W3010996890 creator A5004819903 @default.
• W3010996890 creator A5006107322 @default.
• W3010996890 creator A5010081463 @default.
• W3010996890 creator A5013726855 @default.
• W3010996890 creator A5024822994 @default.
• W3010996890 creator A5026352956 @default.
• W3010996890 creator A5027032896 @default.
• W3010996890 creator A5028192791 @default.
• W3010996890 creator A5031066610 @default.
• W3010996890 creator A5033011774 @default.
• W3010996890 creator A5035250507 @default.
• W3010996890 creator A5036223463 @default.
• W3010996890 creator A5036632964 @default.
• W3010996890 creator A5038010720 @default.
• W3010996890 creator A5039743118 @default.
• W3010996890 creator A5051291364 @default.
• W3010996890 creator A5053696833 @default.
• W3010996890 creator A5054930067 @default.
• W3010996890 creator A5067248479 @default.
• W3010996890 creator A5070291518 @default.
• W3010996890 creator A5073959537 @default.
• W3010996890 creator A5077847034 @default.
• W3010996890 creator A5088608111 @default.
• W3010996890 creator A5091861581 @default.
• W3010996890 date "2020-05-15" @default.
• W3010996890 modified "2023-10-04" @default.
• W3010996890 title "Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> Mutations" @default.
• W3010996890 cites W1480398946 @default.
• W3010996890 cites W1546552389 @default.
• W3010996890 cites W1685156615 @default.
• W3010996890 cites W1778149359 @default.
• W3010996890 cites W1908940658 @default.
• W3010996890 cites W1940083515 @default.
• W3010996890 cites W1990013637 @default.
• W3010996890 cites W1996405911 @default.
• W3010996890 cites W2050211354 @default.
• W3010996890 cites W2065141010 @default.
• W3010996890 cites W2069534609 @default.
• W3010996890 cites W2076178766 @default.
• W3010996890 cites W2081801534 @default.
• W3010996890 cites W2088540000 @default.
• W3010996890 cites W2090029719 @default.
• W3010996890 cites W2121993228 @default.
• W3010996890 cites W2126181231 @default.
• W3010996890 cites W2126709309 @default.
• W3010996890 cites W2133051701 @default.
• W3010996890 cites W2139804581 @default.
• W3010996890 cites W2145980885 @default.
• W3010996890 cites W2151981988 @default.
• W3010996890 cites W2256274387 @default.
• W3010996890 cites W2465575913 @default.
• W3010996890 cites W2494292000 @default.
• W3010996890 cites W2529655703 @default.
• W3010996890 cites W2605449696 @default.
• W3010996890 cites W2605556058 @default.
• W3010996890 cites W2616301769 @default.
• W3010996890 cites W2729330913 @default.
• W3010996890 cites W2747965175 @default.
• W3010996890 cites W2770828094 @default.
• W3010996890 cites W2785841326 @default.
• W3010996890 cites W2790922923 @default.
• W3010996890 cites W2792628494 @default.
• W3010996890 cites W2800224623 @default.
• W3010996890 cites W2885289995 @default.
• W3010996890 cites W2891909134 @default.
• W3010996890 cites W2894066036 @default.
• W3010996890 cites W2898171786 @default.
• W3010996890 cites W2898951197 @default.
• W3010996890 cites W2916137642 @default.
• W3010996890 cites W2958959836 @default.
• W3010996890 cites W2962334030 @default.
• W3010996890 cites W2964827678 @default.
• W3010996890 cites W2990041408 @default.
• W3010996890 cites W2991406229 @default.
• W3010996890 cites W2999801017 @default.
• W3010996890 doi "https://doi.org/10.1158/0008-5472.can-19-3819" @default.
• W3010996890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7392201" @default.
• W3010996890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32193290" @default.
• W3010996890 hasPublicationYear "2020" @default.
• W3010996890 type Work @default.
• W3010996890 sameAs 3010996890 @default.
• W3010996890 citedByCount "38" @default.
• W3010996890 countsByYear W30109968902020 @default.
• W3010996890 countsByYear W30109968902021 @default.
• W3010996890 countsByYear W30109968902022 @default.
• W3010996890 countsByYear W30109968902023 @default.
• W3010996890 crossrefType "journal-article" @default.
• W3010996890 hasAuthorship W3010996890A5004819903 @default.
• W3010996890 hasAuthorship W3010996890A5006107322 @default.
• W3010996890 hasAuthorship W3010996890A5010081463 @default.
• W3010996890 hasAuthorship W3010996890A5013726855 @default.
• W3010996890 hasAuthorship W3010996890A5024822994 @default.
• W3010996890 hasAuthorship W3010996890A5026352956 @default.
• W3010996890 hasAuthorship W3010996890A5027032896 @default.
• W3010996890 hasAuthorship W3010996890A5028192791 @default.
• W3010996890 hasAuthorship W3010996890A5031066610 @default.

• next